Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Accel. buyback
Inv. presentation
Quarterly results
CC transcript
PFIZER INC (PFE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
08/01/2023 8-K Quarterly results
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and the several underwriters listed on Schedule I to the Pricing Agreement",
"Pricing Agreement, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and the several underwriters listed on Schedule I to the Pricing Agreement",
"Indenture, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and The Bank of New York Mellon, as trustee",
"First Supplemental Indenture, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and The Bank of New York Mellon, as trustee",
"Opinion of Margaret M. Madden, Senior Vice President and Corporate Secretary, Chief Governance Counsel of the Company",
"Opinion of Drew & Napier LLC"
05/15/2023 8-K Other Events  Interactive Data
05/02/2023 8-K Quarterly results
05/01/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/13/2023 8-K Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger, by and among Pfizer Inc., Aris Merger Sub, Inc. and Seagen Inc.",
"Pfizer Invests $43 Billion to Battle Cancer",
"Investor Presentation",
"Voting Agreement, by and among Pfizer Inc., Seagen Inc. and Baker Bros. Advisors LP (on behalf of itself and certain stockholders of Seagen Inc. on Schedule A thereto)"
01/31/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE"
12/13/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
04/20/2022 8-K Results of Operations and Financial Condition  Interactive Data
04/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Pfizer Names David M. Denton Chief Financial Officer"
03/29/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/08/2022 8-K Quarterly results
12/15/2021 8-K Quarterly results
11/19/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "PRESS RELEASE EX-99.1"
11/02/2021 8-K Quarterly results
Docs: "PFIZER REPORTS THIRD-QUARTER 2021 RESULTS"
08/18/2021 8-K Quarterly results
07/28/2021 8-K Quarterly results
Docs: "PFIZER REPORTS SECOND-QUARTER 2021 RESULTS"
07/09/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/04/2021 8-K Quarterly results
04/26/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
01/12/2021 8-K Quarterly results
12/14/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Elimination relating to the Series A Preferred Stock and Series B Preferred Stock",
"Restated Certificate of Incorporation"
11/18/2020 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
11/16/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan"
11/13/2020 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial ...
Docs: "Certificate of Designation of Series B Junior Participating Redeemable Preferred Stock"
11/05/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy